COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL studyThomas Chatzikonstantinou, Elżbieta Kalicińska, Anargyros Kapetanakis et al.|Leukemia|2021Cited by 94
Therapeutic strategies and treatment sequencing in patients with chronic lymphocytic leukemia: An international study of ERIC, the European Research Initiative on CLLThomas Chatzikonstantinou, Thomas Longval, Francesca Bacchiarri et al.|HemaSphere|2024Cited by 2
Real-World Evidence on Therapeutic Strategies and Treatment-Sequencing in Patients with Chronic Lymphocytic Leukemia: An International Study of Eric, the European Research Initiative on CLLThomas Chatzikonstantinou, Robert J. Kreitman, Lydia Scarfò et al.|Blood|2021Cited by 1
Greek Registry of Myelofibrosis: Baseline Characteristics and Therapeutic StrategyDamianos Sotiropoulos, Constantinos Tsatalas, Argiris Symeonidis et al.|Blood|2014Cited by 0
Survival Outcomes of Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) Treated in the Chemoimmunotherapy Vs BTK Inhibitor (BTKi) Eras: A European Research Initiative on CLL (ERIC) StudyT C, David Oscier, Eva Minga et al.|Blood|2024Cited by 0